Valproic acid Completed Phase 4 Trials for Schizophrenia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00194025Valproate in Late Life Schizophrenia
NCT00308360Risperidone Alone Vs. Risperidone Plus Valproate in the Treatment of Patients With Schizophrenia and Hostility